Pacer Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.2M | Buy |
+740,817
| New | +$36.2M | 0.09% | 205 |
|
|
2024
Q3 | – | Sell |
-571
| Closed | -$17.5K | – | 2638 |
|
|
2024
Q2 | $17.5K | Sell |
571
-796
| -58% | -$24.3K | ﹤0.01% | 3430 |
|
|
2024
Q1 | $39.8K | Buy |
+1,367
| New | +$39.8K | ﹤0.01% | 3262 |
|
|
2021
Q2 | – | Sell |
-1,327
| Closed | -$63K | – | 1518 |
|
|
2021
Q1 | $63K | Sell |
1,327
-704
| -35% | -$33.4K | ﹤0.01% | 1410 |
|
|
2020
Q4 | $124K | Sell |
2,031
-102
| -5% | -$6.23K | ﹤0.01% | 1331 |
|
|
2020
Q3 | $100K | Buy |
+2,133
| New | +$100K | ﹤0.01% | 1248 |
|
|
2018
Q4 | – | Sell |
-6,384
| Closed | -$300K | – | 928 |
|
|
2018
Q3 | $300K | Buy |
+6,384
| New | +$300K | 0.01% | 953 |
|
|
2018
Q1 | – | Sell |
-1,550
| Closed | -$26K | – | 1109 |
|
|
2017
Q4 | $26K | Buy |
+1,550
| New | +$26K | ﹤0.01% | 1082 |
|